Status: Recruiting
Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic Factor
The aim of the study is to investigate the effect of coenzyme Q10 supplementation (150 mg/b.i.d, 300 mg/d, 12 weeks) on coenzyme Q10, glucose parameters, BDNF, myokines, and cognitive function in mild cognitive impairment (MCI) and Alzheimer's disease (AD) patients who combined with hyperglycemia but without sarcopenia, or with hyperglycemia and pre-sarcopenia.
Participants needed: 100
Trial details
Age: 50-80Biological sex: AllType: InterventionalSponsor: Chung Shan Medical UniversityUpdated: Feb 7, 2024Locations: 1
Eligibility criteria
Clinical diagnosis of mild cognitive impairment (MCI). [+4]
Cancer patients. [+5]